Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).

Journal Article (Journal Article;Review)

Full Text

Duke Authors

Cited Authors

  • Orgel, R; Wojdyla, D; Huberman, D; Halperin, JL; Breithardt, G; Singer, DE; Fox, KAA; Hankey, GJ; Mahaffey, KW; Jones, WS; Patel, MR

Published Date

  • May 2017

Published In

Volume / Issue

  • 10 / 5

PubMed ID

  • 28495674

Pubmed Central ID

  • PMC5485838

Electronic International Standard Serial Number (EISSN)

  • 1941-7705

Digital Object Identifier (DOI)

  • 10.1161/CIRCOUTCOMES.116.003520


  • eng

Conference Location

  • United States